Sire Bioscience Inc (SIRE) 銘柄情報

MISSISSAUGA, Ontario – TheNewswire - March 10, 2021 – Sire Bioscience Inc. (CSE:SIRE) (CNSX:SIRE.CN) (OTC:BLLXF) (FSE:BR1B) (“Sire” or the “Company”) announces that, in response to the ongoing global COVID-19 pandemic, it will host its annual general and special meeting of shareholders (the “Meeting”) by teleconference only, at 11:00 am Pacific Standard Time on Friday, April 9, 2021.

The Company made the decision to hold the Meeting by teleconference after considering Provincial and Federal guidance regarding public gatherings, and to proactively protect the health and wellbeing of the Company’s shareholders, officers, directors and service providers that will participate in the Meeting.

The Company encourages its shareholders to vote their common shares before the proxy cut-off date of Wednesday, April 7, 2021 at 11 am PST and reminds its shareholders that no votes will be accepted at the Meeting.

Shareholders who wish to attend the Meeting can find the details to attend below.

Conference Dial-in Number: 1-888-299-2873 (toll free in Canada) or 1-888-585-9008 (toll-free in the USA)

Conference Room #: 448-444-850

Dial in for any other countries, please contact the Company at 604.737.2303 prior to the Meeting date for dial in particulars.

Eat Beyond Adds SIRE Bioscience to its Portfolio and Extends Marketing Agreement
Wed., March 17, 2021, 9:00 a.m.
VANCOUVER, BC, March 17, 2021 /CNW/ - Eat Beyond Global Holdings Inc. (CSE: EATS) (OTCPK: EATBF) (FSE: 988) ("Eat Beyond" or the "Company"), an investment issuer focused on the global plant-based and alternative food sector, announced it has invested in SIRE Bioscience (CSE: SIRE) ("SIRE").

Eat Beyond Global Holdings Logo (CNW Group/Eat Beyond Global Holdings Inc.)
Eat Beyond Global Holdings Logo (CNW Group/Eat Beyond Global Holdings Inc.)
SIRE is a CPG life science company focused on the plant-based foods and supplements industry. Its products are segmented into three areas: sports nutrition, plant fuel, and plant-based protein.

SIRE recently acquired PlantFuel, Inc. providing SIRE with a solid portfolio of plant-based products. PlantFuel's leadership has scaled brands to over $200 million in sales with more than 50,000 distribution points in 120 different countries.

Fusion Nutrition Inc., which SIRE acquired in 2020, is a Canadian-based, leading supplement company with national distribution. It holds some of the fastest-growing supplements in Canada and numerous category leaders sold in Canada's top five retailers. Fusion is available in 800 locations nationwide.

"Eat Beyond is excited to expand our growing portfolio into the supplements space," Eat Beyond CEO Patrick Morris said. "SIRE has a wide-ranging portfolio of brands, and we believe that the supplements industry is currently in an exciting evolutionary phase and that consumers are increasingly seeking to improve the quality of what they consume. Supplements are becoming less about solely producing aesthetic results, and more about improving overall health. SIRE is on the forefront of this trend."

SIRE will use the funds from this investment for working capital, expansion of the Fusion line of supplement products, and expansion capital.

Marketing Agreement

The Company also announces that it has extended its service contract (the "Service Contract") announced December 2, 2020 with Media Relations Publishing, Carsten Schmider ("Media Relations"), to provide marketing and consulting services, including certain investor relations services, for the purpose of creating market awareness of the Company. The Service Contract extension includes payment of EUR 100,000 for a four-week period commencing March 16, 2021.

About Eat Beyond Global Holdings

Eat Beyond Global Holdings Inc. ("Eat Beyond") (CSE: EATS) (OTCPK: EATBF) (FSE: 988) is an investment issuer that makes it easy to invest in the future of food. Eat Beyond identifies and makes equity investments in global companies that are developing and commercializing innovative food tech as well as plant-based and alternative food products. Led by a team of food industry experts, Eat Beyond is the first issuer of its kind in Canada, providing retail investors with the unique opportunity to participate in the growth of a broad cross-section of opportunities in the alternative food sector, and access companies that are leading the charge toward a smarter, more secure food supply. Learn more: https://eatbeyondglobal.com/

Find Eat Beyond on Social Media on LinkedIn, Instagram, Twitter and Facebook

Cision
Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/eat-beyond-adds-sire-bioscience-to-its-portfolio-and-extends-marketing-agreement-301249339.html

SOURCE Eat Beyond Global Holdings Inc.


Cision
Cision
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2021/17/c2687.html

Sire Bioscience Signs LOI to Acquire Fusion Nutrition Incorporated to Accelerate the SIRE House of Brands Portfolio

TORONTO, Ontario, November 14, 2019, Sire Bioscience Inc. (CSE:SIRE) (OTC:BLLXF) (FSE:BR1B) ("SIRE" or the "Company"), a Health Canada hemp license holder, announced today that it has signed an LOI to acquire all of the outstanding shares of Fusion Nutrition Incorporated ("FUSION"). 


FUSION’S network of 800 points of distribution include Sport Chek, Popeye’s Supplements, GNC Canada, and Supplement King. The $50.84B ** USD sports nutrition industry continues to grow with an expected CAGR of 9.7% to 2025*. This growth is primarily driven by the expansion from traditional core consumers (bodybuilders and elite athletes) to mainstream consumers (recreational athletes, fitness enthusiasts, and overall health and wellness seekers).  


Pursuant to the LOI, SIRE will acquire 100% of FUSION in consideration for the issuance of common shares of SIRE at a price per share price equal to the closing price of SIRE's shares on the trading day immediately prior to the closing of the acquisition, but in any event no less than $0.05 per share, for an aggregate transaction value of between $400,000 to $700,000. 


With FUSION’s experience in the category, SIRE believes that it will be uniquely positioned to launch more relevant and highly customized products at a faster pace.  


According to FUSION President, Ryan Herniman, the union of the CBD and sports nutrition industries is a natural fit. CBD, the non-psychoactive component of the cannabis plant, may have benefits in the reduction of pain and inflammation post-exercise, which may in turn aid in recovery and results. 


“We’ve been studying the applications of cannabinoids for human performance for years and have always felt CBD would be a perfect pairing with our products,” explains Herniman. “With the advent of new regulations, this acquisition makes sense for both parties. SIRE has a team of experts in place to execute at a high level and we are thrilled to be a part of the vision.” 


To learn more about FUSION you can visit their social platforms via @fusionmuscle or fusionmuscle.com. 


About Fusion Nutrition Inc. 

Founded in 1998, FUSION is a Canadian-based, leading supplement company with national distribution. It currently hosts up to 12 brands, including some of the fastest-growing supplements in Canada and numerous category leaders sold in Canada’s top five retailers. FUSION products are developed using the latest research available, with the goal of providing maximum efficacy by supporting the human body in its own natural processes. 


About Sire Bioscience Inc. 

SIRE’s principal business activity is to engage in the investment, production of, and sale of hemp for CBD extraction. SIRE has its wholly owned facility in Leamington, Ontario. The land parcel includes 50 acres of prime horticultural land, with a 160,000 sq. ft. facility of combined greenhouse and indoor space. SIRE’s goal is to become a vertically integrated CPG life science company with its “House of Brands” offering.  


SIRE is headquartered in Toronto, Ontario and is backed by a group of successful entrepreneurs who have extensive experience in the areas of manufacturing, logistics, and renewable energy. 


FOR INFORMATION, CONTACT: 


Sire Bioscience Inc.

E: ir@sirebioscience.com 

Blox Labs Receives CSE Approval for Change of Business And Name Change to Sire Bioscience Inc.
September 9, 2019 - Toronto, Ontario – Blox Labs Inc. (“Blox” or “the Company”) (CSE: BLOX) (Frankfurt: BR1B) (OTC:BLLXF) is pleased to announce that further to its news release dated August 29, 2019, the Company has completed all matters relating to its change of business, including receiving final approval from the Canadian Securities Exchange (“CSE”), completion of a name change to Sire Bioscience Inc. (“Sire”), and pursuant to a CSE bulletin, will commence trading on the CSE under the symbol SIRE on September 11, 2019. The Company will also affect management changes in conjunction with the completion of the transaction. On the listing date, the Board of Directors of Sire will consist of:
• Brian Polla, COO and director
• Jeff Zanini, CEO and director
• Sean McGrath, CFO
• Jerry Habuda, director
• Adrian Burke, director
• Brian Nugent , director
The Company has officially launched its new website at www.sirebioscience.com.

About Sire Bioscience Inc.
Sire is Canadian life sciences company with a focus on the cultivation, production and sale of industrial hemp. Sire is headquartered in Toronto, Ontario and it owns a 50-acre parcel of land, inclusive of a 160,000 sq. ft. state-of-the-art greenhouse, in Leamington, Ontario – a preeminent locale for hemp cultivation in Canada.

For additional information:
Sire Bioscience Inc.
Jeff Zanini
CEO
E: jeff@sirebioscience.com
T: 416-262-0871